DNA repair pathways and the effect of radiotherapy in breast cancer

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Microenvironmental regulation of metastasis

  2009cited by this paper
• Advances in radiotherapy and implications for the next century: a historical perspective.

  2009cited by this paper
• Small-Molecule Drugs Mimicking DNA Damage: A New Strategy for Sensitizing Tumors to Radiotherapy

  2009cited by this paper
• Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast

  2008cited by this paper
• Molecular characterisation of the tumour microenvironment in breast cancer.

  2008cited by this paper
• Dancing on damaged chromatin: functions of ATM and the RAD50/MRE11/NBS1 complex in cellular responses to DNA damage.

  2008cited by this paper
• Her2-positive breast cancer: herceptin and beyond.

  2008cited by this paper
• DNA repair pathways as targets for cancer therapy

  2008cited by this paper
• NBS1 regulates a novel apoptotic pathway through Bax activation.

  2008cited by this paper
• Negative Regulation of AKT Activation by BRCA1.

  2008cited by this paper
• Modelling breast cancer: one size does not fit all

  2007cited by this paper
• DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population

  2007cited by this paper
• Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation

  2007cited by this paper
• Phosphatidylinositol 3-kinase/Akt signaling enhances nuclear localization and transcriptional activity of BRCA1.

  2007cited by this paper
• DNA double-strand break repair: from mechanistic understanding to cancer treatment.

  2007cited by this paper
• The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis

  2007cited by this paper
• Essential role for nuclear PTEN in maintaining chromosomal integrity.

  2007cited by this paper
• Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials

  2007influential reference
• Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis.

  2007cited by this paper
• RAD51 135G>C polymorphism and risk of familial breast cancer in a South American population.

  2007cited by this paper
• RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.

  2007cited by this paper
• Structural model of full‐length human Ku70–Ku80 heterodimer and its recognition of DNA and DNA‐PKcs

  2007cited by this paper
• Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers.

  2006cited by this paper
• Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441.

  2006cited by this paper
• A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers

  2006cited by this paper
• p53 modulates homologous recombination by transcriptional regulation of the RAD51 gene

  2006influential reference
• The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.

  2006cited by this paper
• ATM gene expression is associated with differentiation and angiogenesis in infiltrating breast carcinomas.

  2006cited by this paper
• DNA damage and repair in gastric cancer--a correlation with the hOGG1 and RAD51 genes polymorphisms.

  2006cited by this paper
• Three-dimensional structure of the human DNA-PKcs/Ku70/Ku80 complex assembled on DNA and its implications for DNA DSB repair.

  2006cited by this paper
• Increased NBS1 Expression Is a Marker of Aggressive Head and Neck Cancer and Overexpression of NBS1 Contributes to Transformation

  2006cited by this paper
• HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry

  2006cited by this paper
• Long-term follow-up of the Stockholm randomized trials of postoperative radiation therapy versus adjuvant chemotherapy among ‘high risk’ pre- and postmenopausal breast cancer patients

  2006cited by this paper
• siRNA Targeting NBS1 or XIAP Increases Radiation Sensitivity of Human Cancer Cells Independent of TP53 Status

  2006cited by this paper
• Molecular pathology of ataxia telangiectasia

  2005cited by this paper
• Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

  2005cited by this paper
• DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs.

  2005cited by this paper
• Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

  2005cited by this paper
• Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

  2005cited by this paper
• DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

  2005cited by this paper
• NBS1 knockdown by small interfering RNA increases ionizing radiation mutagenesis and telomere association in human cells.

  2005cited by this paper
• Immunohistochemical expression of DNA repair proteins in familial breast cancer differentiate BRCA2-associated tumors.

  2005influential reference
• High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients

  2005cited by this paper
• Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.

  2005cited by this paper
• Characterisation of the promoter region of the human DNA-repair gene Rad51.

  2005cited by this paper
• Lack of PTEN sequesters CHK1 and initiates genetic instability.

  2005cited by this paper
• NBS1 Expression as a Prognostic Marker in Uveal Melanoma

  2005cited by this paper
• ATM Activation by DNA Double-Strand Breaks Through the Mre11-Rad50-Nbs1 Complex

  2005cited by this paper
• Ku: a multifunctional protein involved in telomere maintenance.

  2005cited by this paper
• Overexpression of NBS1 Contributes to Transformation through the Activation of Phosphatidylinositol 3-Kinase/Akt*

  2005cited by this paper
• Distinct functional domains of Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing radiation

  2004cited by this paper
• Death by Abl: a matter of location.

  2004cited by this paper
• Role of cell cycle in mediating sensitivity to radiotherapy.

  2004influential reference
• Cell death by mitotic catastrophe: a molecular definition

  2004cited by this paper
• Survival after treatment for breast cancer in a geographically defined population

  2004cited by this paper
• Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update

  2004cited by this paper
• Rad51 overexpression promotes alternative double-strand break repair pathways and genome instability

  2004cited by this paper
• Molecular characterization of the tumor microenvironment in breast cancer.

  2004cited by this paper
• Towards an integrated model for breast cancer etiology: The lifelong interplay of genes, lifestyle, and hormones

  2004cited by this paper
• A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers

  2004cited by this paper
• Prognostic significance of BRCA1 expression in sporadic breast carcinomas

  2003cited by this paper
• DNA-PK: the major target for wortmannin-mediated radiosensitization by the inhibition of DSB repair via NHEJ pathway.

  2003cited by this paper
• P53 and radiation responses

  2003cited by this paper
• Altered expression of DNA double‐strand break detection and repair proteins in breast carcinomas

  2003cited by this paper
• HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells

  2003cited by this paper
• Ready to partner

  2003cited by this paper
• The role of p53 in determining sensitivity to radiotherapy

  2003influential reference
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair.

  2003cited by this paper
• BRCA1 gene in breast cancer

  2003cited by this paper
• The role of RAD51 in etoposide (VP16) resistance in small cell lung cancer

  2003cited by this paper
• Overexpression of mammalian Rad51 does not stimulate tumorigenesis while a dominant-negative Rad51 affects centrosome fragmentation, ploidy and stimulates tumorigenesis, in p53-defective CHO cells

  2003cited by this paper
• Breast cancer stem cells revealed

  2003cited by this paper
• Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer.

  2002cited by this paper
• Insights into DNA recombination from the structure of a RAD51–BRCA2 complex

  2002influential reference
• Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.

  2002cited by this paper
• Elevated levels of Rad51 recombination protein in tumor cells.

  2002cited by this paper
• Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray.

  2002cited by this paper
• Fusion Tyrosine Kinases Induce Drug Resistance by Stimulation of Homology-Dependent Recombination Repair, Prolongation of G2/M Phase, and Protection from Apoptosis

  2002cited by this paper
• If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells.

  2001cited by this paper
• Prognostic significance of BRCA1 expression in Japanese sporadic breast carcinomas

  2001cited by this paper
• The Case Against Apoptosis

  2001cited by this paper
• A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.

  2001cited by this paper
• Globocan 2000 : cancer incidence, mortality and prevalence worldwide

  2001cited by this paper
• Role of BRCA2 in control of the RAD51 recombination and DNA repair protein.

  2001cited by this paper
• Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair

  2001cited by this paper
• Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population‐based study

  2001cited by this paper
• Tissue microarrays for rapid linking of molecular changes to clinical endpoints.

  2001cited by this paper
• Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation.

  2001cited by this paper
• Synthesis and function of 3-phosphorylated inositol lipids.

  2001cited by this paper
• A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers

  2001cited by this paper
• The phosphatidylinositide 3'-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase C.

  2001cited by this paper
• PKB/AKT: functional insights from genetic models

  2001cited by this paper
• Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cells.

  2001cited by this paper
• Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

  2000cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• 5-Fluorouracil: Forty-Plus and Still Ticking. A Review of its Preclinical and Clinical Development

  2000cited by this paper
• Defying death after DNA damage

  2000cited by this paper
• Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation.

  2000influential reference
• Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk.

  2000cited by this paper

• No citing papers are available for this paper.